Could a measles vaccine help in the fight against Covid-19?


Months into the pandemic, the World Health Organization (WHO) has published a list of 70 vaccine candidates, with three of those already in the first phases of clinical evaluation.

In one of these efforts, France’s Pasteur Institute is working on making use of a modified measles vaccine to trick the body into producing antibodies against the new coronavirus, according to a report.

The Pasteur Institute is renowned for their fight against infectious diseases, having come up with remedies against a number of diseases, including typhoid fever, tuberculosis, yellow fever and HIV.

According to virologist Frédéric Tangy, nearly all 133 research departments of the institute are actively involved in Covid-19 related research.

How can a measles vaccine fight coronavirus?

Tangy and his team will modify a standard measles vaccine in the hope that it will trigger an immune response against the new coronavirus, similar to the action of the MMR vaccine that is currently used against measles, mumps and rubella.

Benefits of this venture would include the fact that an MMR vaccine is quick and affordable to manufacture, and that a single vaccination can trigger strong and long-lasting immunity.

An MMR vaccine usually works by triggering the body to produce antibodies against measles, mumps and rubella after a live, weakened form of these viruses is injected. The weakened form of these viruses is enough to trigger the immune system to deliver a response, but not strong enough to make you ill.

The same strategy showed promising results when it was used for the institute's vaccine against Chikugunya, a disease caused by Aedes aegypti mosquitos in South Asia. This current vaccine is now in phase thee of its clinical trial.

How long will such a vaccine take to develop?

If this vaccine candidate tuns out to be promising, the University of Pittsburgh’s Centre for Vaccine Research will partner with the Pasteur Institute to start animal testing.

Vials will then be manufactured for the first phase of a clinical trial, which should be able to take place within a year.

Tangy explained that it is vital to have enough time to test for side-effects, as the wrong immune response can be more dangerous than the virus itself.

READ | The new coronavirus: The urgent, but long race for a vaccine

READ | These are the 3 coronavirus vaccines furthest along in development - already in clinical trials

READ | Another coronavirus vaccine being tested in mice

Image credit: Unsplash

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
Rand - Pound
Rand - Euro
Rand - Aus dollar
Rand - Yen
Brent Crude
Top 40
All Share
Resource 10
Industrial 25
Financial 15
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.